General Mills, Inc. filings document material events for a packaged-food company with NYSE-listed common stock and multiple listed debt securities. Recent 8-K reports cover operating results and financial condition, executive and board changes, director independence and committee assignments, bylaw amendments, material-event disclosures, shareholder voting matters and capital-structure disclosures.
The company’s regulatory record also identifies registered securities including common stock and notes with varying maturities, as well as junior subordinated notes. Form 25 filings document the removal from listing and registration of specified note classes on the New York Stock Exchange.
General Mills, Inc. filed a current report to note that it issued a press release on September 17, 2025 reporting financial results for its fiscal quarter ended August 24, 2025. The company’s common stock and several series of notes remain listed on the New York Stock Exchange. The press release is provided as Exhibit 99 and is incorporated by reference, while the financial information furnished under Item 2.02 is not deemed filed for liability purposes under federal securities laws.
The Accountability Board, Inc. is urging General Mills shareholders to vote FOR Proposal 5, which asks the company to adopt a policy separating the roles of Board Chair and CEO. The letter argues that General Mills’ leadership structure, which combines these roles with an independent lead director, has not protected shareholder value, noting that as of May 31, 2025 its five-year total shareholder return was 0.28 versus 5.83 for the GICS 3020 Food Products group and 15.94 for the S&P 500, and its one-year return was -18.01 versus 0.94 and 13.52 for those benchmarks.
The solicitation highlights that a similar independence proposal in 2022 received about 42% support. It also points out that companies where current General Mills directors serve on the board or governance committee—including O’Reilly Auto Parts, Nordstrom, Avnet, Nike, Origin Materials, Elevance Health, Fortune Brands Innovations, Axalta Coating, and Analogic—publicly describe separate Chair and CEO roles or independent chairs as governance “highlights” that support stronger oversight and clearer accountability.
General Mills (GIS) insider notice for proposed sale under Rule 144. The filing shows a proposed sale of 1,629 common shares through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $81,572.18. The securities were acquired and will be sold on 09/12/2025 following a stock option exercise and payment was made in cash.
The filing also lists prior open-market sales by related persons during the past three months: 13,040 shares for $646,001.60 on 08/14/2025, 19,136 shares for $943,005.61 on 08/11/2025, and 6,000 shares for $322,062.00 on 07/02/2025. The filer certifies no undisclosed material adverse information and the notice is executed under the standard Rule 144 representations.
Maria G. Henry, a director of General Mills, Inc. (GIS), received 679 shares of Common Stock on 08/24/2025 as compensation in lieu of a cash retainer under the company’s 2022 Stock Compensation Plan. The reported transaction lists a price of $49.64 per share and shows Ms. Henry’s direct beneficial ownership after the award at 46,277 shares.
The Form 4 indicates this was a non-employee director equity grant and the filing documents the issuance and resulting ownership stake without other changes to derivative holdings or joint filings.
John G. Morikis, a director of General Mills, Inc. (GIS), received 528 shares of Common Stock on 08/24/2025 at an indicated price of $49.64 per share. The filing states the shares were issued to a non-employee director in lieu of a retainer under the 2022 Stock Compensation Plan. After this issuance, Mr. Morikis beneficially owned 14,369 shares, held directly. The Form 4 was signed on behalf of Mr. Morikis by Christopher A. Rauschl on 08/26/2025. The filing records a routine director equity grant and does not disclose any derivative transactions.
General Mills insider filing: Director Kim Goodwin reported a transaction on 08/24/2025 converting a deferred cash retainer into 503 phantom stock units tied to General Mills common stock. Each unit is recorded at a price of $49.64. After the transaction the filing shows the reporting person beneficially owns 1,794.149 shares (direct). The phantom stock units represent the right to receive the cash value of one share each and are payable in cash at the end of the deferral period; the reporting person may move those units into other investments at any time.
Stephen A. Odland, a director of General Mills, Inc. (GIS), reported a change in beneficial ownership. On 08/24/2025 he acquired 503 phantom stock/common stock units by deferring a cash retainer under the company’s Deferred Compensation Plan for Non-Employee Directors. Each unit represents the right to receive the cash value of one share of General Mills common stock; the reported unit price was $49.64. Following the transaction the reporting person beneficially owns 50,189.091 shares (direct). The units are payable in cash at the end of the deferral period and may be transferred into alternative investments. The Form 4 was signed on behalf of Mr. Odland by Christopher A. Rauschl on 08/26/2025.
Jorge A. Uribe, a director of General Mills, Inc. (GIS), reported transactions in Common Stock on 08/24/2025. The filing shows an acquisition entry of 604 shares at a price of $49.64 and a second line reporting 129 shares at the same price, with beneficial ownership reported as 35,729.123 and 35,600.123 shares respectively after the transactions. The filing explains the shares were issued to a non-employee director in lieu of a retainer under the company’s 2022 Stock Compensation Plan. The Form 4 was signed on behalf of Mr. Uribe on 08/26/2025.
Shareholder proposal and company response on pesticide disclosure. The filing argues that publicly disclosing pesticide reductions from General Mills' regenerative agriculture program is essential to assess progress and reduce greenwashing risk, and states that General Mills lags peers in measuring and reporting pesticide use. The company responds that requiring farmers to track pesticide use would add cost and complexity and could jeopardize participation, that regenerative goals extend beyond pesticides, and that it already provides significant disclosures on these initiatives.
Form 144 filed for General Mills (GIS) shows an intended sale of 13,040 common shares on 08/14/2025 through Morgan Stanley Smith Barney, with an aggregate market value of $646,001.60. The filing reports 542,427,490 shares outstanding for the issuer. The securities to be sold were acquired as 7,530 performance shares on 06/27/2022 and 5,510 restricted shares on 06/29/2014. Recent sales by the same person in the past three months total 25,136 shares across trades on 07/02/2025 and 08/11/2025, generating disclosed gross proceeds. The filer certifies they are not aware of undisclosed material adverse information about the issuer.